Avoiding Second Fusion: How an Army Veteran Found Relief with Intra-Annular Fibrin Injection After Failed Surgery

At ValorSpine, we understand the profound impact chronic back pain can have, especially when it stems from service to our nation and persists even after previous surgical interventions. This case study details the journey of John M., an Army veteran who found himself facing the daunting prospect of a second spinal fusion, only to discover a path to relief and restored function through our innovative biologic disc repair approach.

Patient Overview

John M., a 55-year-old retired Army Sergeant First Class, presented to ValorSpine with a complex history of chronic low back pain, radiating into his left leg. His service spanned two decades, including multiple deployments and extensive exposure to physical stressors inherent in infantry life—heavy rucking, parachute jumps, and the concussive forces of combat operations. These experiences, he believed, laid the groundwork for his spinal issues. Eight years prior, John underwent an L4-L5 spinal fusion to address a severe disc herniation and instability that had rendered him almost immobile. While the initial surgery provided some relief, it was short-lived. Over the last three years, his pain steadily worsened, primarily manifesting above and below the fused segment, a common complication known as adjacent segment disease. John described his pain as a constant, deep ache in his lower back, rated consistently at 7/10, flaring to an unbearable 9/10 with any prolonged standing, walking, or bending. The radicular pain in his left leg made sleep difficult and significantly impacted his quality of life.

The Challenge

John’s condition was multifaceted and debilitating. Diagnostic imaging, including MRI, revealed significant degenerative changes at L3-L4 and L5-S1, the segments immediately adjacent to his previous L4-L5 fusion. Both discs exhibited clear signs of dehydration, loss of disc height, and, critically, prominent annular tears. These tears were identified as the primary source of his persistent discogenic pain, exacerbated by the altered biomechanics above and below his fused segment. The L5-S1 disc also showed a contained bulge impinging on the S1 nerve root, contributing to his leg symptoms. John’s pain prevented him from engaging in activities he once cherished, such as golfing, hiking with his wife, and even playing with his grandchildren. He struggled with basic daily tasks, found driving excruciating, and was increasingly isolated. The chronic pain also took a significant toll on his mental health, leading to feelings of frustration and hopelessness. His previous surgical team had recommended another fusion, this time extending from L3 down to S1, a prospect John dreaded due to the risks, prolonged recovery, and the high likelihood of developing further adjacent segment issues.

Previous Treatments Tried

Before seeking help at ValorSpine, John had exhausted a wide array of conservative and interventional treatments following his initial fusion and the onset of adjacent segment disease. These included:

• Extensive Physical Therapy: Over multiple years, John engaged in various physical therapy programs aimed at strengthening his core and improving mobility. While some provided temporary symptomatic relief, they failed to address the underlying disc pathology and the pain always returned.
• Chiropractic Care: Regular chiropractic adjustments offered momentary comfort but did not provide lasting improvement for his discogenic pain and radiculopathy.
• Multiple Epidural Steroid Injections: John underwent at least six epidural steroid injections targeting L3-L4 and L5-S1 over a three-year period. Each injection offered diminishing returns, with relief lasting only a few weeks at best, and the effect eventually became negligible.
• Oral Pain Medications: He was on a regimen of NSAIDs, muscle relaxants, and occasionally prescription opioids to manage his severe pain. While these provided some symptomatic control, they came with undesirable side effects and did not resolve the core problem.
• Nerve Blocks and Radiofrequency Ablation: These procedures were attempted to alleviate facet joint pain, but since the primary source of his pain was determined to be the annular tears and disc degeneration, they offered minimal sustained benefit.

Despite these extensive efforts, John’s pain persisted, and the recommendation for a second, more extensive fusion loomed large, pushing him to explore alternative, less invasive options.

Our Approach

At ValorSpine, our philosophy centers on addressing the root cause of discogenic pain through regenerative and minimally invasive techniques. Upon reviewing John’s comprehensive medical history, diagnostic images, and performing a thorough physical examination, we identified his L3-L4 and L5-S1 discs, particularly the annular tears, as the key drivers of his pain. We recognized that another fusion, while potentially stabilizing, would only further alter spinal mechanics and likely lead to future problems. Our proposed solution was an intra-annular fibrin injection, a precise, image-guided procedure designed to seal painful annular tears and stimulate the body’s natural healing processes within the disc. This approach aims to restore disc integrity, reduce inflammation, and alleviate discogenic pain without the need for invasive surgery.

Our comprehensive strategy involved:

• Precise Diagnosis: Confirming the discogenic origin of pain through advanced imaging and clinical correlation, focusing on the location and severity of annular tears.
• Minimally Invasive Treatment: Utilizing a biologic disc repair technique to target the damaged discs directly.
• Holistic Post-Procedure Care: A structured rehabilitation program designed to support the healing process and gradually restore strength and function.
• Patient Education: Ensuring John understood the procedure, expected recovery timeline, and his role in the healing process.

Treatment Process

John’s treatment at ValorSpine involved a meticulous, multi-step process:

1. Pre-Procedure Evaluation: A detailed assessment ensured John was an ideal candidate for intra-annular fibrin injection. This included a review of all previous records, a physical examination, and a careful analysis of his MRI scans to precisely map the location and extent of the annular tears at L3-L4 and L5-S1.
2. The Procedure: The intra-annular fibrin injection was performed under fluoroscopic (real-time X-ray) guidance to ensure pinpoint accuracy. John was comfortably sedated. A fine needle was carefully advanced into the nucleus of both the L3-L4 and L5-S1 discs, directly targeting the identified annular tears. A specialized fibrin sealant solution was then injected into the damaged annulus. This biologic solution acts as a scaffold, closing the tears and encouraging the body’s natural regenerative mechanisms to repair the disc wall. The entire procedure was outpatient and took approximately an hour.
3. Immediate Post-Procedure Care: Following the injection, John rested for a short period before being discharged with specific instructions. He was advised to limit strenuous activity for several weeks to allow the fibrin to stabilize and initial healing to commence. Mild discomfort or soreness at the injection sites was expected and managed with non-opioid pain relievers.
4. Structured Rehabilitation: John enrolled in a tailored post-procedure rehabilitation program. This phased approach began with gentle mobility exercises and core stabilization. Over the subsequent weeks and months, the intensity gradually increased, focusing on strengthening the supporting musculature of the spine, improving posture, and restoring functional movement patterns. The program emphasized patience and consistency, acknowledging that true disc repair is a gradual process.
5. Follow-up and Monitoring: John had regular follow-up appointments at 1 month, 3 months, 6 months, and 12 months. These visits included clinical evaluations, pain score assessments, and functional status reviews to monitor his progress and adjust his rehabilitation as needed.

The Results

John’s journey to recovery was progressive, consistent with the typical healing timeline for biologic disc repair. His experience highlights the potential for significant improvement and avoidance of further invasive surgery:

• Week 1-2: John experienced some initial soreness, which is common as the body begins its healing response. He diligently followed the rest and gentle movement protocol.
• Month 1: John reported a subtle but noticeable reduction in his baseline pain. The sharp, incapacitating flares were less frequent, and his overall pain score had decreased from a consistent 7/10 to around 5/10. He found he could sit for longer periods without significant discomfort.
• Month 3: By this point, John reported a significant improvement. His low back pain had reduced to a consistent 3-4/10. The radicular pain in his left leg had nearly resolved, only presenting as a mild tingling after prolonged activity. He was able to walk for over 30 minutes without needing to stop and found himself sleeping more soundly. He was actively participating in his physical therapy, gaining strength and confidence.
• Month 6: John’s progress continued to accelerate. His pain levels stabilized at an impressive 2/10, allowing him to resume many of his beloved activities. He was back on the golf course, playing nine holes without significant pain, and enjoying longer hikes with his wife. He no longer required daily pain medication. John stated he felt “better than he had in years” and was profoundly grateful to have avoided a second fusion.
• Month 12: At his one-year follow-up, John’s pain remained low, fluctuating between 1-2/10, typically only after unusually strenuous activity. He had regained much of his functional independence and quality of life. An updated MRI showed favorable changes in the treated discs, with evidence of improved hydration and reduced inflammation. While the disc structure was not completely restored to pre-injury state (which is not typically expected), the functional healing of the annular tears was evident, correlating with his sustained pain relief.

John’s outcome represents a moderate to significant improvement (approximately 70% reduction in pain scores), a truly transformative result given his previous prognosis. He successfully avoided a complex, high-risk second spinal fusion, preserving his spinal mobility and functionality.

Key Takeaways

John M.’s case powerfully illustrates several critical points regarding chronic discogenic pain and advanced spine care:

1. Adjacent Segment Disease is a Significant Challenge: John’s experience highlights the common and often debilitating issue of adjacent segment disease following spinal fusion. This condition underscores the importance of conservative and regenerative options to preserve spinal health and avoid the cascade of further surgeries.
2. Precise Diagnosis is Paramount: Identifying the specific annular tears at L3-L4 and L5-S1 as the primary pain generators, even in the context of previous surgery, was crucial for successful treatment. Our diagnostic rigor ensures treatments target the true source of pain.
3. Intra-Annular Fibrin Injection as a Viable Alternative: For patients like John, facing the prospect of repeat fusion surgery, biologic disc repair offers a compelling, minimally invasive alternative. By addressing the disc pathology directly and promoting natural healing, it can provide profound and lasting relief without the risks and extensive recovery associated with open surgery.
4. Restoration of Quality of Life: Beyond pain reduction, the ultimate goal of ValorSpine’s treatments is to restore patients’ ability to live full, active lives. John’s return to golfing, hiking, and cherished family activities demonstrates the true success of our approach.
5. Patient Compliance is Key: John’s dedication to his post-procedure rehabilitation protocol was instrumental in his excellent outcome. The biologic healing process is greatly aided by adherence to activity restrictions and a structured recovery plan.

“After my first fusion, I thought my life was over when they told me I needed another one. ValorSpine gave me my life back. The pain is so much better, and I can actually enjoy my retirement with my family. This treatment was a game-changer for me.”

— John M., Retired Army SFC and ValorSpine Patient

If you would like to read more, we recommend this article: Avoiding Second Fusion: How an Army Veteran Found Relief with Intra-Annular Fibrin Injection After Failed Surgery